{"id":403808,"date":"2020-12-21T10:03:36","date_gmt":"2020-12-21T15:03:36","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=403808"},"modified":"2020-12-21T10:03:36","modified_gmt":"2020-12-21T15:03:36","slug":"gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\/","title":{"rendered":"GDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n NEW YORK<\/span>, Dec. 21, 2020<\/span> \/PRNewswire\/ — Attorney Advertising– Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against\u00a0GoodRx Holdings, Inc.\u00a0(“GoodRx” or “the Company”) (NASDAQ: GDRX) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired GoodRx securities between\u00a0September 23, 2020 to November 16, 2020<\/span>, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com\/gdrx<\/a>. \u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n

\n

\n
\n \"Bronstein,
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.\u00a0<\/p>\n

\n

The Complaint alleges that at the time of the initial public stock offering (the “IPO”), the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. Specifically, the complaint alleges that on September 23, 2020<\/span>, GoodRX completed its IPO, selling about 34.6 million shares at $33.00<\/span> per share. The complaint alleges that Defendants timed the IPO before Amazon announced its online pharmaceutical business, making their statements in the Registration Statement and during the Class Period about GoodRx’s competitive position materially false and\/or misleading. The lawsuit also alleges that due to these materially false and\/or misleading statements, GoodRx Class A common stock traded at artificially inflated prices of more than $64<\/span> per share during the Class Period.<\/p>\n

Then, just weeks later on November 17, 2020<\/span>, Amazon announced its Prime Rx plan and a discount card program, which was said to make it “simple for customers to compare prices and purchase medications for home delivery, all in one place.” Following this news, GoodRx Class A common stock dropped 23%, from $46.72<\/span> per share to $36.21<\/span> on November 17, 2020<\/span>.<\/p>\n

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com\/gdrx<\/a>\u00a0or you may contact Peretz Bronstein, Esq.<\/span> or his Investor Relations Analyst, Yael Hurwitz<\/span> of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in GoodRx\u00a0you have until February 16, 2021<\/span> to request that the Court appoint you as lead plaintiff.\u00a0 Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.<\/p>\n

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.\u00a0Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.\u00a0 In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration.\u00a0 \u00a0Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein<\/span> or Yael Hurwitz<\/span>
212-697-6484 | info@bgandg.com<\/a><\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/gdrx-shareholder-alert-bronstein-gewirtz–grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021-301196649.html<\/a><\/p>\n

SOURCE Bronstein, Gewirtz & Grossman, LLC<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire NEW YORK, Dec. 21, 2020 \/PRNewswire\/ — Attorney Advertising– Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against\u00a0GoodRx Holdings, Inc.\u00a0(“GoodRx” or “the Company”) (NASDAQ: GDRX) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired GoodRx securities between\u00a0September 23, 2020 to November 16, 2020, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com\/gdrx. \u00a0\u00a0\u00a0\u00a0\u00a0 This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.\u00a0 The Complaint alleges that at the time of the initial public stock offering (the “IPO”), the Company issued … <\/p>\n

Continue reading “GDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-403808","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nGDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK, Dec. 21, 2020 \/PRNewswire\/ — Attorney Advertising– Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against\u00a0GoodRx Holdings, Inc.\u00a0(“GoodRx” or “the Company”) (NASDAQ: GDRX) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired GoodRx securities between\u00a0September 23, 2020 to November 16, 2020, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com\/gdrx. \u00a0\u00a0\u00a0\u00a0\u00a0 This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.\u00a0 The Complaint alleges that at the time of the initial public stock offering (the “IPO”), the Company issued … Continue reading "GDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-21T15:03:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/439152\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"GDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021\",\"datePublished\":\"2020-12-21T15:03:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\\\/\"},\"wordCount\":481,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/439152\\\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\\\/\",\"name\":\"GDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/439152\\\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg\",\"datePublished\":\"2020-12-21T15:03:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/439152\\\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/439152\\\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\/","og_locale":"en_US","og_type":"article","og_title":"GDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021 - Market Newsdesk","og_description":"PR Newswire NEW YORK, Dec. 21, 2020 \/PRNewswire\/ — Attorney Advertising– Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against\u00a0GoodRx Holdings, Inc.\u00a0(“GoodRx” or “the Company”) (NASDAQ: GDRX) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired GoodRx securities between\u00a0September 23, 2020 to November 16, 2020, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com\/gdrx. \u00a0\u00a0\u00a0\u00a0\u00a0 This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.\u00a0 The Complaint alleges that at the time of the initial public stock offering (the “IPO”), the Company issued … Continue reading \"GDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-21T15:03:36+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/439152\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"GDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021","datePublished":"2020-12-21T15:03:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\/"},"wordCount":481,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/439152\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\/","name":"GDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/439152\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg","datePublished":"2020-12-21T15:03:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/439152\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/439152\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-goodrx-holdings-inc-investors-of-class-action-and-lead-plaintiff-deadline-february-16-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"GDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/403808","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=403808"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/403808\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=403808"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=403808"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=403808"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}